Robert S. Epstein, director at Veracyte Inc. (VCYT), made one open market sale of shares in the last year, totaling $753 thousand. His latest transaction occurred on October 1, 2025. This ranks him 5,565th out of nearly 12,000 insiders by sale value, well below the average of $8.6 million across six transactions. Epstein recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 1, 2025 | VERACYTE, INC. | $VCYT | EPSTEIN ROBERT S | Director | M | Stock Option (right to buy) | 10000 | $0.00 | 0.0000 | 79,946,386 | 100.00% | 0.01% |
| Oct. 1, 2025 | VERACYTE, INC. | $VCYT | EPSTEIN ROBERT S | Director | S | Common Stock | 21473 | $35.08 | 62,446.0000 | 79,946,386 | 25.59% | 0.03% |
| Oct. 1, 2025 | VERACYTE, INC. | $VCYT | EPSTEIN ROBERT S | Director | M | Common Stock | 10000 | $7.94 | 83,919.0000 | 79,946,386 | 13.53% | 0.01% |
| June 18, 2025 | VERACYTE, INC. | $VCYT | EPSTEIN ROBERT S | Director | A | Common Stock | 9321 | $0.00 | 73,919.0000 | 78,163,217 | 14.43% | 0.01% |
| May 29, 2025 | FATE THERAPEUTICS INC | $FATE | EPSTEIN ROBERT S | Not found | A | Stock Option (Right to Buy) | 55000 | $0.00 | 55,000.0000 | 113,685,177 | 9999.99% | 0.05% |
| May 21, 2025 | ILLUMINA, INC. | $ILMN | EPSTEIN ROBERT S | Director | A | Common Stock | 3780 | $0.00 | 22,139.0000 | 201,000,000 | 20.59% | 0.00% |
| Jan. 6, 2025 | VERACYTE, INC. | $VCYT | EPSTEIN ROBERT S | Director | M | Common Stock | 20000 | $8.04 | 64,598.0000 | 78,163,217 | 44.85% | 0.03% |
| Jan. 6, 2025 | VERACYTE, INC. | $VCYT | EPSTEIN ROBERT S | Director | M | Stock Option (right to buy) | 20000 | $0.00 | 0.0000 | 78,163,217 | 100.00% | 0.03% |
| Nov. 12, 2024 | VERACYTE, INC. | $VCYT | EPSTEIN ROBERT S | Director | M | Common Stock | 15000 | $8.04 | 59,598.0000 | 78,465,000 | 33.63% | 0.02% |
| Nov. 12, 2024 | VERACYTE, INC. | $VCYT | EPSTEIN ROBERT S | Director | S | Common Stock | 15000 | $38.32 | 44,598.0000 | 78,465,000 | 25.17% | 0.02% |
| Nov. 12, 2024 | VERACYTE, INC. | $VCYT | EPSTEIN ROBERT S | Director | M | Stock Option (right to buy) | 15000 | $0.00 | 20,000.0000 | 78,465,000 | 42.86% | 0.02% |
| June 13, 2024 | VERACYTE, INC. | $VCYT | EPSTEIN ROBERT S | Director | A | Common Stock | 11473 | $0.00 | 44,598.0000 | 72,644,487 | 34.64% | 0.02% |
| June 7, 2024 | FATE THERAPEUTICS INC | $FATE | EPSTEIN ROBERT S | Not found | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 98,411,162 | 9999.99% | 0.04% |
| May 16, 2024 | ILLUMINA, INC. | $ILMN | EPSTEIN ROBERT S | Director | A | Common Stock | 2622 | $0.00 | 18,306.0000 | 199,000,000 | 16.72% | 0.00% |
| May 15, 2024 | ILLUMINA, INC. | $ILMN | EPSTEIN ROBERT S | Director | F | Common Stock | 612 | $115.01 | 15,684.0000 | 199,000,000 | 3.76% | 0.00% |
| June 9, 2023 | VERACYTE, INC. | $VCYT | EPSTEIN ROBERT S | Director | A | Common Stock | 9674 | $0.00 | 33,125.0000 | 71,549,204 | 41.25% | 0.01% |
| June 6, 2023 | FATE THERAPEUTICS INC | $FATE | EPSTEIN ROBERT S | Director | A | Stock Option (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |